NationDrugs.com Announces Xarelto to their Canada Online Pharmacy Catalog

MONTREAL - April 21, 2015 - PRLog -- NationDrugs.com, a trusted and established online pharmacy intermediary has added Xarelto to their medication catalog.

Xarelto (Rivaroxaban) is an anticoagulant (blood thinner) that prevents the formation of blood clots. Xarelto is used to prevent or treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism). A DVT can occur after certain types of surgery.

Through NationDrugs.com, patients have access to brand name and generic medications at much lower prices.

Xarelto (Rivaroxaban) 10mg/15mg/20mg can be found in the NationDrugs.com catalog at http://www.nationdrugs.com/drugs/xarelto

All orders required a valid prescription from your doctor.

All prescriptions are filled by a professionally registered pharmacist and licensed pharmacy.

About NationDrugs.com

NationDrugs.com is one of Canada's leading Canadian pharmacy intermediaries established in 2002. NationDrugs.com is dedicated to providing our patients with quality, safe medications at affordable prices, and more importantly, ensuring that their health and well being is the first priority.

NationDrugs.com fills orders for thousands of uninsured and underinsured individuals and clinics every year. With a product catalog of over 3000 medications on both brand name and generic labels, patients can expect considerable savings by taking advantage of lower international prices.

NationDrugs.com uses affiliated international pharmacies and fulfillment centers located in the Canada, Italy, the UK, New Zealand, India, Switzerland, South Africa, Israel, and Fiji.

For more information on Xarelto (Rivaroxaban), please visit http://www.nationdrugs.com/drugs/xarelto

Customer Support

Our patient care service center can be reached by phone 9:00am - 5:00pm EST, Monday to Friday at 1-866-799-3435. Reference Order Code 6500 when speaking to a patient care specialist to receive special web pricing.